To ensure the progress of our COST Action, CONNECT has established 5 Working Groups (WGs).
Working Group 1 (WG1)
The main objective of WG1 is to strengthen collaboration on pre-clinical models for kidney disease and brain research. This main objective will be reached by achieving below objectives:
Working Group 2 (WG2)
Clinical research and clinical trials
The main objective of WG2 is to disseminate knowledge on clinical research and clinical trials on cognitive impairment in CKD. Thereby, more, and more successful clinical trials can be conducted on the prevalence, risk factors, and best treatments of MCI-CKD. This main objective will be reached by achieving below objectives:
Working Group 3 (WG3)
The main objective of WG3 is to strengthen collaborations between nephrologists and neurologists to ensure they speak a common language. When their knowledge is up to date on MCI-CKD, clinicians will be able to cross-diagnose beyond their own expertise and refer patients to neurologists or nephrologists for further diagnosis and treatment when appropriate. This main objective will be reached by achieving below objectives: